African Americans and men with severe COPD have a high prevalence of osteoporosis

COPD: Journal of Chronic Obstructive Pulmonary Disease

Volumn 5, Issue 5, 2008, Pages 291-297

  Li, Lihua ^a   Brennan, Kathleen J ^a   Gaughan, John P ^a   Ciccolella, David E ^a   Kuzma, Anne Marie ^a   Criner, Gerard J ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bone mineral density; COPD; Osteopenia; Osteoporosis

Indexed keywords

PREDNISONE;

ADULT; ARTICLE; CARDIOPULMONARY EXERCISE TEST; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DEMOGRAPHY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FORCED EXPIRATORY VOLUME; FRACTURE; HUMAN; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; OSTEOPENIA; OSTEOPOROSIS; PRIORITY JOURNAL;

AFRICAN AMERICANS; BONE DENSITY; COHORT STUDIES; COMORBIDITY; FEMALE; FRACTURES, STRESS; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OSTEOPOROSIS; PHILADELPHIA; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS;

EID: 55249105735     PISSN: 15412555     EISSN: 15412563     Source Type: Journal    
DOI: 10.1080/15412550802363329     Document Type: Article

References (26)

1. Biskobing DM. COPD and osteoporosis. Chest 2002; 121:609-620.
2. Goldstein MF, Fallon Jr JJ, Harning R. Chronic glucocorticoid therapy-induce osteoporosis in patients with obstructive lung disease. Chest 1999; 116:1733-1749.
3. National Institues of Health Consensus Development Panel on Osteoporosis. Prevention, diagnosis, and therapy. JAMA 2001;285:785-795.
4. Seeman, E., Wagner H, Offord K, Kumar R, Johnson W, Riggs B. Differential effects of endocrine dysfunction on the axial and appendicular skeleton. J Clin Invest 1982; 69:1302-1309.
5. NHLBI/WHO. Global Initiative for Chronic Obstructive Lung Disease (GOLD) workshop report: global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease, 2005. Available at: http://www.goldcopd.com. Accessed November 11, 2005.
6. Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA, Plata VP, Cabral HJ. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in Chronic Obstructive Pulmonary Disease. N Engl J Med 2004; 350:1005-1012.
7. American Thoracic Society. Lung function testing: selection of reference values and interpretative strategies. Am Rev Respir Dis 1991; 144:1202-1218.
8. American Thoracic Society. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med 1995; 152:1107-1136.
9. American Thoracic Society. Single-breath carbon monoxide diffusing capacity (transfer factor): recommendations for a standard technique-1995 update. Am J Respir Crit Care Med 1995;152:2185-2198.
10. Crapo RO, Morris AH, Gardner RM. Reference spirometric values using techniques and equipment that meets ATS recommendations. Am Rev Respir Dis 1981; 123(6):659-664.
11. American Thoracic Society. ATS Statement: Guidelines for the Six-Minute Walk Test. Am J Respir Crit Care Med 2002; 166:111-117.
12. Weinstein MS, Martin UJ, Crookshank AD, Chatila W, Vance GB, Gaughan JP, Furukawa S, Criner GJ. Mortality and functional performance in severe emphysema after lung volume reduction or transplant. COPD (In press).
13. Iqbal F, Michaelson J, Thaler L, et al. Declining bone mass in men with chronic pulmonary disease: contribution of glucocorticoid treatment, body mass index, and gonadal function. Chest 1999;116:1616-1624.
14. Eastell R. Treatment of postmenopausal osteoporosis. N Engl J Med 1998; 338:736-746.
15. Ionescu AA, Schoon E. Osteoporosis in chronic obstructive pulmonary disease. Eur Respir J Suppl 2003 Nov; 46:64s-75s.
16. Tschopp O, Boehler A, Speich R, Weder W, Seifert B, Russ EW, Schmid C. Osteoporosis before lung transplantation: association with low body mass index, but not with underlying disease. Am J Transplant 2002 Feb; 2(2):167-172.
17. Shane E, Silverberg SJ, Donovan D, Papadopoulos A, Staron RB, Addesso V, Jorgesen B, McGregor C, Schulman L. Osteoporosis in lung transplantation candidates with end-stage pulmonary disease. Amer J Med 1996; 101(3):262-269.
18. National Institues of Health Consensus Development Panel on Osteoporosis. Prevention, diagnosis, and therapy. JAMA 2001;285:785-795.
19. Sin D. The risk of osteoporosis in caucasian men and women with Obstructive Airways Disease. Amer J Med 2003; 114:10-14.
20. Mc Evoy CE, Ensrud KE, Bender E, Harry K. Association between corticosteroid use and vertebral fractures in older men with Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 1998; 157(3):704-709.
21. Looker AC, Orwoll ES, Johnston CC Jr, Lindsay RL, Wahner HW, Dunn WL, Calvo MS, Harris TB, Heyse SP. Prevalence of low femoral bone density in older U.S. adults from NHANES III. J Bone Miner Res 1997; 12:1761-1768.
22. Vrieze A, de Greef MH, Wýkstra PJ, Wempe JB. Low bone mineral density in COPD patients related to worse lung function, low weight and decreased fat-free mass. Osteoporosis Int 2007; March 9.
23. Margolis KL, Ensrud KE, Schreiner PJ, Tabor HK. Body size and risk for clinical fractures in old women. Study of Osteoporotic Fractures Research Group. Ann Intern Med 2000; 133:123-127.
24. Katsura H, Kida K. A comparison of bone mineral density in elderly female patients with COPD and bronchial asthma. Chest 2002; 122:1949-1955.
25. Schlaich C, Minne HW, Bruckner T. Reduced pulmonary function in patients with spinal osteoporotic fractures. Osteoporos Int 1998;8(3):261-267.
26. Papaioannou A, Parkinson W, Ferko N, Probyn L. Prevalence of vertebral fractures among patients with chronic obstructive pulmonary disease in Canada. Osteoporos Int 2003; 14(11):913-917.